Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).

Haruka Maeda,Nobuo Saito,Ataru Igarashi,Masayuki Ishida, Kazuya Suami, Ai Yagiuchi,Yuya Kimura,Masaru Komino,Hiromi Arai,Toru Morikawa,Iori Motohashi, Rei Miyazawa, Tetsu Moriyama,Hiroshi Kamura,Mayumi Terada,Osamu Kuwamitsu,Tomoichiro Hayakawa,Eiichiro Sando,Yasuji Ohara,Osamu Teshigahara,Motoi Suzuki,Konosuke Morimoto

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2022）

引用 9|浏览8

暂无评分

摘要

mRNA COVID-19 vaccines had high effectiveness against symptomatic SARS-CoV-2 infections in Japan during July-September 2021, when the Delta variant was dominant nationwide.

查看译文

关键词

COVID-19,Delta,Japan,SARS-CoV-2,vaccine effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要